Cargando…

Disulfide Bridged Nanoparticles of Thiolated Sodium Alginate and Eudragit RS100 for Oral Delivery of Paclitaxel: In Vitro and In Vivo Evaluation

[Image: see text] Most biopharmaceutics classification system (BCS) class IV drugs have limited oral bioavailability due to poor solubility and poorer permeability. This work aims to investigate the possibility of utilizing disulfide bridged nanoparticles to improve BCS IV drug solubility and oral a...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalid, Hafiz Muhammad Bilal, Rasul, Akhtar, Shah, Shahid, Abbas, Ghulam, Mahmood, Abid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018692/
https://www.ncbi.nlm.nih.gov/pubmed/36936332
http://dx.doi.org/10.1021/acsomega.3c00400
_version_ 1784907866862256128
author Khalid, Hafiz Muhammad Bilal
Rasul, Akhtar
Shah, Shahid
Abbas, Ghulam
Mahmood, Abid
author_facet Khalid, Hafiz Muhammad Bilal
Rasul, Akhtar
Shah, Shahid
Abbas, Ghulam
Mahmood, Abid
author_sort Khalid, Hafiz Muhammad Bilal
collection PubMed
description [Image: see text] Most biopharmaceutics classification system (BCS) class IV drugs have limited oral bioavailability due to poor solubility and poorer permeability. This work aims to investigate the possibility of utilizing disulfide bridged nanoparticles to improve BCS IV drug solubility and oral absorption. Disulfide bridged nanoparticles were made using thiolated sodium alginate (TSA) and thiolated eudragit RS100 (TERS100). This study used paclitaxel (PTL) as a model drug to create PTL-loaded nanoparticles using the air oxidation approach. PTL-loaded nanoparticles boosted the solubility of PTL by over 11 times (∼59 μg/mL). The nanoparticles had particle sizes of 103 nm, polydispersity indices of 0.034, and zeta potentials of −21 mV, respectively. Nanoparticles demonstrated 75.34% and 89.18% entrapment and loading efficiency of PTL, respectively. The PTL release data from nanoparticles had good sustained release properties. The effective permeability of PTL from nanoparticles was 2.19-fold higher than that of pure PTL suspension. The relative bioavailability of PTL with disulfide bridged nanoparticles was 237.11%, which was much higher than that of PTL suspension, according to the pharmacokinetic data. These results show that disulfide bridged nanoparticles have a wide range of clinical applications.
format Online
Article
Text
id pubmed-10018692
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-100186922023-03-17 Disulfide Bridged Nanoparticles of Thiolated Sodium Alginate and Eudragit RS100 for Oral Delivery of Paclitaxel: In Vitro and In Vivo Evaluation Khalid, Hafiz Muhammad Bilal Rasul, Akhtar Shah, Shahid Abbas, Ghulam Mahmood, Abid ACS Omega [Image: see text] Most biopharmaceutics classification system (BCS) class IV drugs have limited oral bioavailability due to poor solubility and poorer permeability. This work aims to investigate the possibility of utilizing disulfide bridged nanoparticles to improve BCS IV drug solubility and oral absorption. Disulfide bridged nanoparticles were made using thiolated sodium alginate (TSA) and thiolated eudragit RS100 (TERS100). This study used paclitaxel (PTL) as a model drug to create PTL-loaded nanoparticles using the air oxidation approach. PTL-loaded nanoparticles boosted the solubility of PTL by over 11 times (∼59 μg/mL). The nanoparticles had particle sizes of 103 nm, polydispersity indices of 0.034, and zeta potentials of −21 mV, respectively. Nanoparticles demonstrated 75.34% and 89.18% entrapment and loading efficiency of PTL, respectively. The PTL release data from nanoparticles had good sustained release properties. The effective permeability of PTL from nanoparticles was 2.19-fold higher than that of pure PTL suspension. The relative bioavailability of PTL with disulfide bridged nanoparticles was 237.11%, which was much higher than that of PTL suspension, according to the pharmacokinetic data. These results show that disulfide bridged nanoparticles have a wide range of clinical applications. American Chemical Society 2023-03-03 /pmc/articles/PMC10018692/ /pubmed/36936332 http://dx.doi.org/10.1021/acsomega.3c00400 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Khalid, Hafiz Muhammad Bilal
Rasul, Akhtar
Shah, Shahid
Abbas, Ghulam
Mahmood, Abid
Disulfide Bridged Nanoparticles of Thiolated Sodium Alginate and Eudragit RS100 for Oral Delivery of Paclitaxel: In Vitro and In Vivo Evaluation
title Disulfide Bridged Nanoparticles of Thiolated Sodium Alginate and Eudragit RS100 for Oral Delivery of Paclitaxel: In Vitro and In Vivo Evaluation
title_full Disulfide Bridged Nanoparticles of Thiolated Sodium Alginate and Eudragit RS100 for Oral Delivery of Paclitaxel: In Vitro and In Vivo Evaluation
title_fullStr Disulfide Bridged Nanoparticles of Thiolated Sodium Alginate and Eudragit RS100 for Oral Delivery of Paclitaxel: In Vitro and In Vivo Evaluation
title_full_unstemmed Disulfide Bridged Nanoparticles of Thiolated Sodium Alginate and Eudragit RS100 for Oral Delivery of Paclitaxel: In Vitro and In Vivo Evaluation
title_short Disulfide Bridged Nanoparticles of Thiolated Sodium Alginate and Eudragit RS100 for Oral Delivery of Paclitaxel: In Vitro and In Vivo Evaluation
title_sort disulfide bridged nanoparticles of thiolated sodium alginate and eudragit rs100 for oral delivery of paclitaxel: in vitro and in vivo evaluation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018692/
https://www.ncbi.nlm.nih.gov/pubmed/36936332
http://dx.doi.org/10.1021/acsomega.3c00400
work_keys_str_mv AT khalidhafizmuhammadbilal disulfidebridgednanoparticlesofthiolatedsodiumalginateandeudragitrs100fororaldeliveryofpaclitaxelinvitroandinvivoevaluation
AT rasulakhtar disulfidebridgednanoparticlesofthiolatedsodiumalginateandeudragitrs100fororaldeliveryofpaclitaxelinvitroandinvivoevaluation
AT shahshahid disulfidebridgednanoparticlesofthiolatedsodiumalginateandeudragitrs100fororaldeliveryofpaclitaxelinvitroandinvivoevaluation
AT abbasghulam disulfidebridgednanoparticlesofthiolatedsodiumalginateandeudragitrs100fororaldeliveryofpaclitaxelinvitroandinvivoevaluation
AT mahmoodabid disulfidebridgednanoparticlesofthiolatedsodiumalginateandeudragitrs100fororaldeliveryofpaclitaxelinvitroandinvivoevaluation